137 related articles for article (PubMed ID: 15265128)
1. Diclofenac-induced antibodies against red blood cells are heterogeneous and recognize different epitopes.
Sachs UJ; Santoso S; Röder L; Smart E; Bein G; Kroll H
Transfusion; 2004 Aug; 44(8):1226-30. PubMed ID: 15265128
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia.
Bougie D; Johnson ST; Weitekamp LA; Aster RH
Blood; 1997 Jul; 90(1):407-13. PubMed ID: 9207477
[TBL] [Abstract][Full Text] [Related]
3. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
[TBL] [Abstract][Full Text] [Related]
5. Misdiagnosis in patients with diclofenac-induced hemolysis: new cases and a concise review.
Ahrens N; Genth R; Kiesewetter H; Salama A
Am J Hematol; 2006 Feb; 81(2):128-31. PubMed ID: 16432863
[TBL] [Abstract][Full Text] [Related]
6. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
Arndt PA; Leger RM; Garratty G
Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
[TBL] [Abstract][Full Text] [Related]
7. The first case of drug-induced immune hemolytic anemia due to hydrocortisone.
Martinengo M; Ardenghi DF; Tripodi G; Reali G
Transfusion; 2008 Sep; 48(9):1925-9. PubMed ID: 18565121
[TBL] [Abstract][Full Text] [Related]
8. [Detection of drug-induced antibodies to erythrocytes in the gel test].
Kroll H; Salama A; Berghöfer H; Ernst-Schlegel M; Mueller-Eckhardt C
Beitr Infusionsther; 1993; 31():162-7. PubMed ID: 7693248
[TBL] [Abstract][Full Text] [Related]
9. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.
Johnson ST; Fueger JT; Gottschall JL
Transfusion; 2007 Apr; 47(4):697-702. PubMed ID: 17381629
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced hemolytic anemias: increasing complications to therapeutic interventions.
Wright MS
Clin Lab Sci; 1999; 12(2):115-8. PubMed ID: 10387489
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin-induced immune hemolysis: new cases and a concise review of the literature.
Mayer B; Yürek S; Salama A
Transfusion; 2010 May; 50(5):1135-8. PubMed ID: 20051057
[TBL] [Abstract][Full Text] [Related]
12. Immune complex-mediated haemolytic anaemia and Evans syndrome induced by diclofenac.
de Quirós JF; Pinto V; Hevia S; Vigón R
Vox Sang; 1997; 72(2):121-3. PubMed ID: 9088082
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the immunogenicity of diclofenac and diclofenac metabolites.
Naisbitt DJ; Sanderson LS; Meng X; Stachulski AV; Clarke SE; Park BK
Toxicol Lett; 2007 Jan; 168(1):45-50. PubMed ID: 17123753
[TBL] [Abstract][Full Text] [Related]
14. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug.
Cunha PD; Lord RS; Johnson ST; Wilker PR; Aster RH; Bougie DW
Transfusion; 2000 Jun; 40(6):663-8. PubMed ID: 10864985
[TBL] [Abstract][Full Text] [Related]
15. Diclofenac-induced antibodies against RBCs and platelets: two case reports and a concise review.
Meyer O; Hoffmann T; Aslan T; Ahrens N; Kiesewetter H; Salama A
Transfusion; 2003 Mar; 43(3):345-9. PubMed ID: 12675720
[TBL] [Abstract][Full Text] [Related]
16. First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS.
Pérez S; Barceló D
Anal Chem; 2008 Nov; 80(21):8135-45. PubMed ID: 18821734
[TBL] [Abstract][Full Text] [Related]
17. [A patient with an extremely severe immunohaemolytic anemia due to diclofenac].
Heyning FH; Hoogendoorn M; Harvey MS; Nortier JW
Ned Tijdschr Geneeskd; 2004 Jan; 148(1):37-9. PubMed ID: 14750454
[TBL] [Abstract][Full Text] [Related]
18. Blood dyscrasias secondary to non-steroidal anti-inflammatory drugs.
Miescher PA
Med Toxicol; 1986; 1 Suppl 1():57-70. PubMed ID: 3547002
[TBL] [Abstract][Full Text] [Related]
19. Roles of diclofenac and its metabolites in immune activation associated with acute hepatotoxicity in TgCYP3A4/hPXR-humanized mice.
Jiang W; Dai T; Xie S; Ding L; Huang L; Dai R
Int Immunopharmacol; 2020 Sep; 86():106723. PubMed ID: 32615451
[TBL] [Abstract][Full Text] [Related]
20. Immune hemolytic anemia associated with sulindac.
Johnson FP; Hamilton HE; Liesch MR
Arch Intern Med; 1985 Aug; 145(8):1515-6. PubMed ID: 4026480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
